- Sonova reported an adjusted EBITA of CHF 325.2 million for the first half, which is below the estimated CHF 340.8 million.
- Total sales reached CHF 1.83 billion, slightly surpassing the estimate of CHF 1.82 billion.
- Hearing Instruments sales were stable at CHF 1.69 billion, matching the estimates.
- Cochlear Implants sales outperformed expectations, reaching CHF 147.6 million against the estimated CHF 142.7 million.
- EBITA from Hearing Instruments was CHF 309.7 million, falling short of the expected CHF 331.6 million.
- Cochlear Implants EBITA was almost on target at CHF 15.8 million, compared to the CHF 16 million estimate.
- For the year 2025, Sonova forecasts adjusted EBITA growth between 7% and 11%.
- Sales growth is forecasted to be between 6% and 9% for 2025.
- Current market analyst recommendations for Sonova include 7 buys, 12 holds, and 4 sells.
A look at Sonova Holding Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Sonova Holding AG’s long-term outlook appears promising based on the Smartkarma Smart Scores. With a strong momentum score of 5, the company seems to be gaining positive traction in the market. This suggests that the company is performing well and generating momentum that may continue in the future.
Additionally, Sonova Holding scores well in growth, resilience, and value, with scores of 4, 3, and 2 respectively. These scores indicate that the company has good potential for future growth, shows resilience in uncertain market conditions, and offers value to investors. While the dividend score is moderate at 2, the overall outlook for Sonova Holding seems positive based on these Smart Scores.
### Summary: Sonova Holding AG provides hearing care solutions, designing, developing, and manufacturing hearing systems worldwide, including wireless communication systems and cochlear implant systems. ###
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
